PR484a : 前列腺癌组织芯片,附WHO标准分级、Gleason分级、Gleason评分、TNM和临床分期,24例/48点,替代PR484
  • ¥805.00
产品详细描述 前列腺腺癌组织微阵列芯片,包含腺癌14例,转移癌及前列腺炎各1例,前列腺增生5例,平滑肌瘤1例,正常前列腺组织2例,每例取两点(同一病人组织在上下两行同一位置点样)
点 数 48
西安艾丽娜生物组织芯片 PR484a
例 数 24
行 数 6
列 数 8
直径(mm) 1.5
厚度(µm) 5
组织阵列类型 石蜡包埋
种 属 人类
应 用 Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
注释 1. 请在实验前60°烤片30分钟; 2. 请选择温和的修复方式,以免造成组织脱落; 3. 收到产品后请在4°保存,并在3个月内使用。
Mouseover and click individual cores to view high resolution images.
Slide Label: US Biomax, Inc. Tissue Array
12345678
AProProProProProProProPro
BProProProProProProProPro
CProProProProProProLymPro
DProProProProProProProPro
EProProProProProProProPro
FProProProProProProProPro
Legend: Lym - Lymph node, Pro - Prostate

- Benign tumor, - Hyperplasia, - Malignant tumor (stage IIA), - Malignant tumor (stage III), - Malignant tumor (stage IV), - Metastasis, - Normal tissue

Specification Sheet (Sortable), tissue IDs are available in exported Excel files.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

挑选其它组织芯片与此芯片比较相同例数:
 

写评论

登录注册后再评论
  收藏
  下载图像(由于组织分层原因,H&E图不一定完全与所购产品相同) (确保浏览器弹窗没有被阻止)
  转换说明书为PDF
  转换说明书为Excel
由于组织分层导致的您下载的说明书或图片可能与您收到的产品略有差异,如有需要请联系销售人员,可提供与您购买产品流水号最近的HE说明书
 
  • 浏览次数: 358
  • 型号: PR484a
  • 库存状态: 有库存

标签: 转移癌, 每例双点